Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 6/20 | 0.41 |
| ▸ | ADH1C | P00326 | 5/20 | 0.41 |
| ▸ | ADH1B | P00325 | 3/20 | 0.41 |
| ▸ | ADH4 | P08319 | 1/20 | 0.39 |
| ▸ | SHBG | P04278 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | MMP2 | P08253 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | ADH7 | P40394 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21114300 | 1.00 | ADH1A (0.41) | ADH1AADH1CADH1BADH4SHBG | |
| SCHEMBL21114234 | 1.00 | ADH1A (0.41) | ADH1AADH1CADH1BADH4SHBG | |
| SCHEMBL11258783 | 1.00 | ADH1A (0.41) | ADH1AADH1CADH1BADH4SHBG | |
| SCHEMBL12216593 | 1.00 | ADH1A (0.41) | ADH1AADH1CADH1BADH4SHBG | |
| SCHEMBL21114287 | 1.00 | ADH1A (0.41) | ADH1AADH1CADH1BADH4SHBG | |
| SCHEMBL7136561 | 1.00 | ADH1A (0.41) | ADH1AADH1CADH1BADH4SHBG | |
| SCHEMBL21114321 | 1.00 | ADH1A (0.41) | ADH1AADH1CADH1BADH4SHBG | |
| SCHEMBL2179467 | 0.97 | — | — | |
| SCHEMBL12216595 | 0.97 | — | — | |
| SCHEMBL96256 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 486 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| EP-2940005-B1 | NITRILE COMPOUND, METHOD OF PREPARATION THEREOF AND FRAGRANCE COMPOSITION COMPRISING THE NITRILE COMPOUND | KAO CORP (JP) | 2017-04-05 | — | — | EP | claimed |
| CN-104884431-B | Nitrile compound | KAO CORP. (JP) | 2016-11-30 | — | — | CN | claimed |
| US-9447362-B2 | Nitrile compound | KAO CORPORATION (JP) | 2016-09-20 | — | — | US | claimed |
| EP-2812316-B1 | AGENT FOR INHIBITING ODOR OF PYRAZINE DERIVATIVES | KAO CORP (JP) | 2016-08-17 | — | — | EP | claimed |
| US-20150353480-A1 | NITRILE COMPOUND | KAO CORPORATION (JP) | 2015-12-10 | — | — | US | claimed |
| US-9200237-B2 | 4,8-dimethyl-4,9-decadienenitrile | KAO CORPORATION (JP) | 2015-12-01 | — | — | US | claimed |
| EP-2940005-A1 | NITRILE COMPOUND | Kao Corporation (JP) | 2015-11-04 | — | — | EP | claimed |
| CN-104884431-A | Nitrile compound | KAO CORP | 2015-09-02 | — | — | CN | claimed |
| EP-2812316-A2 | AGENT FOR INHIBITING ODOR OF PYRAZINE DERIVATIVES | Kao Corporation (JP) | 2014-12-17 | — | — | EP | claimed |
| CN-1242760-A | Process for preparing polyols | NESTE OY (FI) | 2000-01-26 | — | — | CN | claimed |
| EP-0948476-A1 | PROCESS FOR THE PREPARATION OF POLYVALENT ALCOHOLS | Neste Chemicals Oy (FI) | 1999-10-13 | — | — | EP | claimed |
| WO-1998029374-A1 | PROCESS FOR THE PREPARATION OF POLYVALENT ALCOHOLS | NESTE CHEMICALS OY (FI) | 1998-07-09 | — | — | WO | claimed |
| EP-0326959-B1 | Perfume base composition comprising 2-cyclohexylpropanal and process for the preparation of this compound | KAO CORP (JP) | 1994-03-30 | — | — | EP | claimed |
| US-4978653-A | Derivative of 2-cyclohexylpropanal and perfumery composition comprising the same | KAO CORPORATION (JP) | 1990-12-18 | — | — | US | claimed |
| EP-0358091-A2 | Derivative of 2-cyclohexylpropanal and perfumery composition comprising the same | KAO CORPORATION (JP) | 1990-03-14 | — | — | EP | claimed |
| EP-0326959-A2 | Perfume base composition comprising 2-cyclohexylpropanal and process for the preparation of this compound | KAO CORPORATION (JP) | 1989-08-09 | — | — | EP | claimed |
| US-4436729-A | ANTIBIOTICS, BACTERICIDES | SCHERING CORPORATION (US) | 1984-03-13 | — | — | US | claimed |
| US-4435388-A | Tylosin 20-imino-20-deoxo-4\"-acyl derivatives, pharmaceutical compositions and method of use | SCHERING CORPORATION (US) | 1984-03-06 | — | — | US | claimed |
| US-4181810-A | FROM THE 2-SUBSTITUTED ETHANAL AND FORMALDEHYDE USING AN ACID ION EXCHANGER; HYDROGENATION OF REACTION PRODUCT | BAYER AKTIENGESELLSCHAFT (DE) | 1980-01-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150353480-A1 | NITRILE COMPOUND | NOS1, NOS2, NOS3 | ADH1A 621/4885ADH1C 241/4885ADH1B 1708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.